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It has recently been shown that bacteria and viruses can be delivered to the
brain parenchyma without evoking an immune response. These experiments
demonstrate that there are no cells within the brain parenchyma that can
initiate a primary immune response, and that the drainage of pathogens from
the brain parenchyma is distinct from that documented for soluble proteins. A
persistent pathogen in the brain parenchyma can become a target for the
immune system following peripheral sensitisation, and this may lead to
bystander tissue damage. These observations may have consequences for
vaccination of persons with central nervous system HIV infection. Journal of
NeuroVirology (2000) 6, S86 – S89.
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Microglia are the resident macrophages of the
central nervous system. When compared to other
tissue macrophages the microglia have a switched
off or downregulated phenotype (Perry, 1994). In
addition to the microglia there are other popula-
tions of macrophages associated with the CNS
namely the perivascular cells (Graeber et al, 1989)
and the macrophages of the choroid plexus and
meninges (Matyszak et al, 1992). The physiological
relevance of the downregulated phenotype of the
microglia is not well understood but the dementia
associated with HIV clearly highlights the impor-
tance of this phenotype. In HIV-dementia, the
infected microglia and possibly also neighbouring
uninfected cells, become activated and these
activated microglia secrete a spectrum of molecules
that may cause neuronal dysfunction or death
(Gendelman et al, 1994). Microglia become acti-
vated following diverse insults and injuries to the
brain and in both rodent and human CNS
upregulate, or synthesise de novo, antigens that
are not expressed by microglia in the normal brain.
The appearance of MHC Class II on microglia has
repeatedly led to the suggestion that microglia are
the antigen presenting cells (APCs) of the CNS. In
contrast, there is evidence that it is the perivascular
macrophages that are the APCs of the CNS (Hickey
and Kimura, 1988). Although it is possible to isolate
the microglia from the CNS and investigate their
antigen presenting capacity in vitro, unless this is
done rapidly, and under the appropriate conditions,
the cells de-differentiate in vitro (see below). We
have thus addressed the question in vivo. Are there
cells in the CNS parenchyma that are able to initiate
a primary immune response?
To explore this question we injected bacillus
Calmette-Gue´rin (BCG) directly into the CNS. By
using focal injections of the mycobacterium, in a
volume of one microlitre or less, we can study
whether there are differences in the responsiveness
of the different compartments of the brain, for
example, the ventricles versus the parenchyma.
The differential innate inflammatory response in
the ventricles, meninges, and parenchyma follow-
ing challenge with pro-inflammatory agents has
been well demonstrated (Anderson et al, 1992;
Anthony et al, 1997). The injection of endotoxin,
or interleukin-1b, into the adult brain parenchyma
produces a florid inflammatory response in the
meninges but only a very modest inflammatory
response in the parenchyma.
Injection of heat-killed BCG into the ventricles of
the rat produces an acute inflammatory response that
evolves into a delayed-type hypersensitivity (DTH)
response over a period of several days (Matyszak and
Perry, 1996a). This response is essentially indis-
tinguishable from that seen in the skin. When heat-
killed BCG are injected into the brain parenchyma
(carefully avoiding the ventricular system) there is
an acute inflammatory response, as we might expect,
but in marked contrast to the ventricles or skin there
is no subsequent T-cell recruitment and the inflam-
matory response does not develop into a typical DTH
response: the blood-brain barrier repairs and the
recruited myelomoncytic cells are cleared (Matys-
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zak and Perry, 1995). Immunocytochemical studies
demonstrate that the BCG is phagocytosed by cells of
the mononuclear phagocyte lineage and it may
remain within these cells for up to 1 year after the
injection (Figure 1a). There is no evidence of
microglia activation in the region of the BCG deposit
(Figure 1b). Ultrastructual studies and immunogold
labelling demonstrate that the BCG remains within
phagolysosomes of both perivascular macrophages
and microglia (Matyszak et al, 1997).
The absence of a typical DTH response within the
brain parenchyma shows that there are no cells in
the brain parenchyma that are able to carry antigen
back to the lymphoid tissue and present it naı¨ve T-
cells. There are, thus, no dendritic cells (Steinman,
1991) in the brain parenchyma that can initiate a
primary immune response although there are such
cells in the choroid plexus and meninges (Matyszak
and Perry, 1996b; McMenamin, 1999).
The absence of a DTH response against the BCG
deposited within the brain parenchyma is some-
what surprising given that soluble antigens such as
albumin have been shown to rapidly drain from the
brain parenchyma to the cervical lymph nodes
(Cserr and Knopf, 1992). We therefore looked for
evidence that the BCG within the brain might have
induced an atypical immune response that was not
expressed as a typical DTH response (Matyszak and
Perry, 1998). Injection of BCG into the pinna of the
ear leads to synthesis of antibodies to PPD, which
are readily detected in the serum. Following the
same BCG challenge to the pinna, T-cells isolated
from spleen and cervical lymph nodes proliferate
when confronted with PPD, and a contact sensitiv-
ity response to PPD is readily demonstrated in the
ear opposite to the BCG deposit. However, injection
of the same amount of BCG into the brain
parenchyma failed to sensitise the immune system
and no antibodies to PPD were generated, there was
no evidence from T-cell proliferation assays or
contact sensitivity assays that the immune system
had seen BCG antigens (Matyszak and Perry, 1998).
In essence the immune system was wholly naive to
the presence of the BCG within the brain parench-
yma. The absence of an immune response to the
BCG within the brain parenchyma would appear to
be at variance with studies on antigen drainage from
the brain (Cserr and Knopf, 1992) but of course
bacteria, and viruses, are not soluble proteins. The
lack of responsiveness in the CNS parenchyma is
not restricted to heat-killed BCG but has also been
found after small injections of heat- killed Cornye-
bacterium parvum and live BCG (Mastyzak and
Perry, unpublished observations), a replication-
deficient adenovirus (Brynes et al, 1996) and
influenza virus (Stevenson et al, 1997). The differ-
ential immune response to pathogens in the CNS
compartments has obvious parallels with the
immune response to tissue transplantation in the
CNS (Sloan et al, 1991).
The isolation from the immune system is not
absolute. In animals with a BCG deposit within the
brain parenchyma a subsequent peripheral chal-
lenge with BCG will lead to a DTH response at the
site of the initial BCG deposit within the brain,
(Matyszak and Perry, 1995). T-cells and macro-
Figure 1 Photomicrographs to illustrate how heat-killed BCG may remain sequestered behind the blood-brain barrier without evoking
a DTH response, but may act as a target for a DTH following peripheral challenge. (a) Immunocytochemical localisation of BCG in
perivascular macrophages 1 year after injection into the brain parenchyma. Note the absence of any leucocyte cuffing around the
vessels that would be indicative of a DTH response. (b) The resident microglia in the region of the BCG deposit shown in (a) are
revealed with antibodies against the complement receptor type 3 (OX42). The microglia show no evidence of activation. (c) One year
after the injection of heat-killed BCG into the brain parenchyma the animal was injected subcutaneously with BCG to sensitise the
immune system. Two weeks later a typical DTH response is present at the site of the original BCG deposit in the brain with large
numbers of macrophages and T-cells forming a lesion.




phages infiltrate the tissue and around the granulo-
ma there are many activated microglia (Figure 1c).
The recruited leucocytes damage the blood-brain
barrier and damage the neural tissue, both myelin
and axons. It is clear that there are cells within the
brain parenchyma that are able to present the BCG
antigens to the peripherally primed T-cells as we
might expect from numerous studies an experi-
mental allergic encephalomyelitis (Wekerle, 1993).
In peripheral tissues there are a number of cell types
that can support a secondary immune response and
several cell types have been suggested to act as
antigen presenting cells in the brain parenchyma.
Astrocytes have had a somewhat chequered history
in regard to their role as APCs but the absence of
MHC Class II antigen on these cells in vivo makes it
unlikely that they are directly involved in presenta-
tion to CD4 T-cells (see Sedgwick and Hickey, 1996
for review). Although it is commonly stated that
microglia are the antigen presenting cells in the
brain it seems unlikely that they are responsible for
T-cell proliferation in these secondary responses.
Sedgwick and colleagues have developed a
protocol that allows the microglia to be rapidly
isolated from the brain so as to maintain their
phenotype (Sedgwick et al, 1991; Ford et al, 1995).
The microglia are CD45
low
expressing cells in
contrast to the CD45
high
population which are likely
to be perivascular macrophages and some residual
meningeal macrophages. The CD45
high
cells will
induce proliferation of a myelin basic protein T-cell
line in the presence of antigen. The CD45
low
cells do
not induce T-cell proliferation but instead induce a
state of anergy and even direct a percentage of the T-
cells to undergo apoptosis (Ford et al, 1996). Similar
results demonstrating the lack of T-cell prolifera-
tion have been obtained with microglia isolated
from the mouse brain (Carson et al, 1998). Thus, the
notion that microglia are the APCs of the CNS that
induce T-cell proliferation is clearly not correct and
these experiments show rather that the microglia
may play an important role in protecting the brain
parenchyma from the unwanted attentions of
autoreactive T-cells that enter the tissue.
In the normal brain there are no dendritic cells
within the brain parenchyma. However, following
the initiation of a DTH response in the brain
parenchyma directed against the BCG and in
animals with EAE there are significant numbers of
OX62 positive cells within the lesions (Matyshak
and Perry, 1996b). The antigen recognised by OX62
is an integrin present on dendritic cells (Brennan
and Puklavec, 1992). The factors that recruit the
dendritic cells to these lesions have not been
studied. It remains an intriguing question as to
whether these dendritic cells can traffic back to
lyphoid tissue bearing CNS antigens and present
these antigens to naı¨ve T-cells.
Conclusion
These experiments have shown that there are no
antigen presenting dendritic cells within the CNS
parenchyma although cells with this capacity exist
within the ventricular and meningeal compart-
ments. Thus, a pathogen may remain in the brain
parenchyma undetected by the immune system.
The entry of a pathogen into the brain parenchyma
without prior recognition by the immune system
could occur in sub-clinical infections or in im-
munocompromised individuals. Vaccination against
the pathogen, or recovery of a compromised
immune system, with subsequent recognition of
the antigen peripherally may lead to an immune
assault on the pathogen in the brain with bystander
tissue damage. These observations may be relevant
to the HIV seropositive individual who may not
only harbour HIV within the brain but also a
number of other pathogens.
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